14
06/26/22 Hepatocellular Hepatocellular Carcinoma Carcinoma One of the most common malignancies Incidence: 1 M (annual) Ratio 4M:1F US: MR 1.9/100,000/year (low incidence) Africa: 5-20/100,000/year (moderate) Asia: 23-150/100,000/year (high)

Hepatocellular carcinoma

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Hepatocellular carcinoma

04/10/23

Hepatocellular CarcinomaHepatocellular Carcinoma

One of the most common malignancies Incidence: 1 M (annual) Ratio 4M:1F US: MR 1.9/100,000/year (low

incidence) Africa: 5-20/100,000/year (moderate) Asia: 23-150/100,000/year (high)

Page 2: Hepatocellular carcinoma

04/10/23

Table 88-1Table 88-1

Page 3: Hepatocellular carcinoma

04/10/23

Etiologic FactorsEtiologic Factors

Hepatitis C Virus: US: 4M carriers 10% cirrhosis 5% HCC (20,000)

Hepatitis B Virus: High association with HBeAg+ High HBVDNA viral load

Page 4: Hepatocellular carcinoma

04/10/23

Table 88-2Table 88-2

Page 5: Hepatocellular carcinoma

04/10/23

Clinical FeaturesClinical Features

Abdominal pain Anorexia Weight loss Weakness Ascites Jaundice Hematemesis Bone pain asymptomatic

Hepatomegaly Ascites Abdominal bruits Splenomegaly Muscle wasting Jaundice Dilated superf veins Palmar erythema edema

Page 6: Hepatocellular carcinoma

04/10/23

Paraneoplastic syndromesParaneoplastic syndromes

Hypoglycemia Erythrocytosis Hypercalcemia Hypercholesterolemia Dysfibrogenemia Carcinoid syndrome Gynecomastia, testicular atrophy Thrombocytopenia Leukopenia

Page 7: Hepatocellular carcinoma

04/10/23

Table 88-4Table 88-4

Page 8: Hepatocellular carcinoma

04/10/23

Laboratory InvestigationsLaboratory Investigations

Ultrasonography Alpha Feto Protein CT Scan MRI Others: Hep B, Hep C, HBV DNA Liver biopsy

Page 9: Hepatocellular carcinoma

04/10/23

HCC ScreeningHCC Screening

High risk groups: cirrhosis, HBV, HCV, +Family history of HCC AFP determination Ultrasonography Biannual

Page 10: Hepatocellular carcinoma

04/10/23

TherapyTherapy

Surgical resection Local ablation: RFA – heat; 3-4cm size Injection therapy: ethanol; 3x; 3 cm size Liver transplant Systemic chemotherapy Regional chemotherapy: TACE (doxorubicin, cisplatin)

Page 11: Hepatocellular carcinoma

04/10/23

Figure 88-1Figure 88-1

Page 12: Hepatocellular carcinoma

04/10/23

Other tumorsOther tumors

Cholangiocarcinoma: mucin-producing AdenoCA arising from bile ducts; acc to

anatomic sites – intrahepatic, hilar, peripheral; Klatskin(CBD bifurcation); Asians Chlonorchis sinensis ( liver fluke); surgery for distal and hilar lesions

Gall bladder CA: worse prognosis; 4F:1M; Calculous cholecystitis; surgery

Page 13: Hepatocellular carcinoma

04/10/23

Hepatic metastasesHepatic metastases

Colon Pancreas breast

Page 14: Hepatocellular carcinoma

04/10/23

Benign tumorsBenign tumors

Hemangioma Adenoma Focal nodular hyperplasia Predominantly females